<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 56-year-old woman with adult <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>) diagnosed 17 years previously presented with a fusiform <z:hpo ids='HP_0002617'>aneurysm</z:hpo> manifesting as <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002315'>headache</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>She had suffered no major hemorrhagic complications, although her platelet counts were between 3.0 x 10(9)/l and 50.0 x 10(9)/l </plain></SENT>
<SENT sid="2" pm="."><plain>Magnetic resonance angiography identified a fusiform <z:hpo ids='HP_0002617'>aneurysm</z:hpo> of the right vertebral artery </plain></SENT>
<SENT sid="3" pm="."><plain>Endovascular trapping after high-dose gammaglobulin with steroid therapy was performed </plain></SENT>
<SENT sid="4" pm="."><plain>The patient received antiplatelet therapy to prevent <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The parent artery and <z:hpo ids='HP_0002617'>aneurysm</z:hpo> were completely occluded with no hemorrhagic complications </plain></SENT>
<SENT sid="6" pm="."><plain>Endovascular treatment is considered safe in patients with <z:chebi fb="0" ids="16039">ITP</z:chebi>, although careful periprocedural management of platelet count is required </plain></SENT>
</text></document>